These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 27346245

  • 1. Precision medicine in age-specific non-small-cell-lung-cancer patients: Integrating biomolecular results into clinical practice-A new approach to improve personalized translational research.
    Vavalà T, Monica V, Lo Iacono M, Mele T, Busso S, Righi L, Papotti M, Scagliotti GV, Novello S.
    Lung Cancer; 2017 May; 107():84-90. PubMed ID: 27346245
    [Abstract] [Full Text] [Related]

  • 2. Screening for EGFR and KRAS mutations in non-small cell lung carcinomas using DNA extraction by hydrothermal pressure coupled with PCR-based direct sequencing.
    Liu Y, Wu BQ, Zhong HH, Hui P, Fang WG.
    Int J Clin Exp Pathol; 2013 May; 6(9):1880-9. PubMed ID: 24040454
    [Abstract] [Full Text] [Related]

  • 3. Molecular spectrum of somatic EGFR and KRAS gene mutations in non small cell lung carcinoma: determination of frequency, distribution pattern and identification of novel variations in Indian patients.
    Das BR, Bhaumik S, Ahmad F, Mandsaurwala A, Satam H.
    Pathol Oncol Res; 2015 Jul; 21(3):675-87. PubMed ID: 25637496
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Distribution of KRAS, DDR2, and TP53 gene mutations in lung cancer: An analysis of Iranian patients.
    Fathi Z, Mousavi SAJ, Roudi R, Ghazi F.
    PLoS One; 2018 Jul; 13(7):e0200633. PubMed ID: 30048458
    [Abstract] [Full Text] [Related]

  • 7. EGFR and KRAS molecular genotyping for pulmonary carcinomas: Feasibility of a simple and rapid technique implementable in any department of pathology.
    Thomas De Montpréville V, Ghigna MR, Lacroix L, Lemoine A, Besse B, Mercier O, Fadel É, Dorfmuller P, Le Chevalier T, Institut d’Oncologie Thoracique.
    Pathol Res Pract; 2017 Jul; 213(7):793-798. PubMed ID: 28554746
    [Abstract] [Full Text] [Related]

  • 8. KRAS mutations in non-small-cell lung cancer and colorectal cancer: implications for EGFR-targeted therapies.
    Maus MK, Grimminger PP, Mack PC, Astrow SH, Stephens C, Zeger G, Hsiang J, Brabender J, Friedrich M, Alakus H, Hölscher AH, Lara P, Danenberg KD, Lenz HJ, Gandara DR.
    Lung Cancer; 2014 Feb; 83(2):163-7. PubMed ID: 24331409
    [Abstract] [Full Text] [Related]

  • 9. The prognostic effect of single and multiple cancer-related somatic mutations in resected non-small-cell lung cancer.
    Jao K, Tomasini P, Kamel-Reid S, Korpanty GJ, Mascaux C, Sakashita S, Labbé C, Leighl NB, Liu G, Feld R, Bradbury PA, Hwang DM, Pintilie M, Tsao MS, Shepherd FA.
    Lung Cancer; 2018 Sep; 123():22-29. PubMed ID: 30089591
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11.
    La Fleur L, Falk-Sörqvist E, Smeds P, Berglund A, Sundström M, Mattsson JS, Brandén E, Koyi H, Isaksson J, Brunnström H, Nilsson M, Micke P, Moens L, Botling J.
    Lung Cancer; 2019 Apr; 130():50-58. PubMed ID: 30885352
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prospective Validation of Rapid Plasma Genotyping for the Detection of EGFR and KRAS Mutations in Advanced Lung Cancer.
    Sacher AG, Paweletz C, Dahlberg SE, Alden RS, O'Connell A, Feeney N, Mach SL, Jänne PA, Oxnard GR.
    JAMA Oncol; 2016 Aug 01; 2(8):1014-22. PubMed ID: 27055085
    [Abstract] [Full Text] [Related]

  • 16. Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement.
    Kim HR, Shim HS, Chung JH, Lee YJ, Hong YK, Rha SY, Kim SH, Ha SJ, Kim SK, Chung KY, Soo R, Kim JH, Cho BC.
    Cancer; 2012 Feb 01; 118(3):729-39. PubMed ID: 21720997
    [Abstract] [Full Text] [Related]

  • 17. Clinical next-generation sequencing in patients with non-small cell lung cancer.
    Hagemann IS, Devarakonda S, Lockwood CM, Spencer DH, Guebert K, Bredemeyer AJ, Al-Kateb H, Nguyen TT, Duncavage EJ, Cottrell CE, Kulkarni S, Nagarajan R, Seibert K, Baggstrom M, Waqar SN, Pfeifer JD, Morgensztern D, Govindan R.
    Cancer; 2015 Feb 15; 121(4):631-9. PubMed ID: 25345567
    [Abstract] [Full Text] [Related]

  • 18. Genetic mutation screen in early non--small-cell lung cancer (NSCLC) specimens.
    Bar J, Damianovich M, Hout Siloni G, Dar E, Cohen Y, Perelman M, Ben Nun A, Simansky D, Yellin A, Urban D, Onn A.
    Clin Lung Cancer; 2014 Mar 15; 15(2):159-65. PubMed ID: 24370118
    [Abstract] [Full Text] [Related]

  • 19. Immunohistochemical Loss of LKB1 Is a Biomarker for More Aggressive Biology in KRAS-Mutant Lung Adenocarcinoma.
    Calles A, Sholl LM, Rodig SJ, Pelton AK, Hornick JL, Butaney M, Lydon C, Dahlberg SE, Oxnard GR, Jackman DM, Jänne PA.
    Clin Cancer Res; 2015 Jun 15; 21(12):2851-60. PubMed ID: 25737507
    [Abstract] [Full Text] [Related]

  • 20. Detection of EML4-ALK fusion genes in non-small cell lung cancer patients with clinical features associated with EGFR mutations.
    Shaozhang Z, Xiaomei L, Aiping Z, Jianbo H, Xiangqun S, Qitao Y.
    Genes Chromosomes Cancer; 2012 Oct 15; 51(10):925-32. PubMed ID: 22736493
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.